IMPRODIA
Improdia’s mission is to optimize personalized treatments for patients suffering from pathologies characterized by chronic inflammation. In the last half century the incidence and prevalence of these cases are steadily increasing, with further rises expected. Improdia is developing a kit, based on revolutionary biomarkers, that can evaluate the individuals’ immune status and inflammatory conditions by means of a simple, rapid, reliable and non-invasive blood test. This immune status detecting golden standard kit will enable Improdia to be a world leader in this widespread medical field.
IMPRODIA
Industry:
Health Care
Founded:
2012-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.improdia.co.il
Total Employee:
1+
Status:
Active
Contact:
+972-54-4800-067
Email Addresses:
[email protected]
Total Funding:
3 M ILS
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
SpIntellx, Inc.
Revolutionizing Computational Pathology for Precision Medicine
Current Employees Featured
